Effect of eculizumab and recombinant human soluble thrombomodulin combination therapy in a 7-year-old girl with atypical hemolytic uremic syndrome due to anti-factor H autoantibodies
about
Effect of eculizumab and recombinant human soluble thrombomodulin combination therapy in a 7-year-old girl with atypical hemolytic uremic syndrome due to anti-factor H autoantibodies
description
2013 nî lūn-bûn
@nan
2013 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Effect of eculizumab and recom ...... o anti-factor H autoantibodies
@ast
Effect of eculizumab and recom ...... o anti-factor H autoantibodies
@en
type
label
Effect of eculizumab and recom ...... o anti-factor H autoantibodies
@ast
Effect of eculizumab and recom ...... o anti-factor H autoantibodies
@en
prefLabel
Effect of eculizumab and recom ...... o anti-factor H autoantibodies
@ast
Effect of eculizumab and recom ...... o anti-factor H autoantibodies
@en
P2093
P2860
P1433
P1476
Effect of eculizumab and recom ...... o anti-factor H autoantibodies
@en
P2093
Akira Takei
Eisaku Ito
Motoko Chiga
Shohei Ariji
Shuki Mizutani
Tomohiro Morio
Tomohiro Udagawa
Yaeko Motoyoshi
Yu Matsumura
P2860
P2888
P304
P356
10.1007/S13730-013-0097-7
P50
P577
2013-09-12T00:00:00Z
P6179
1010880650